STERIS Stock: A Buying Opportunity After Recent Gains, or Priced for Perfection?
STERIS plc (NYSE: STE) shares have climbed nearly 8% over the last quarter, extending a multi-year rally for the infection prevention specialist. With the stock trading below some intrinsic value estimates but at a premium industry multiple, investors are weighing whether its growth trajectory justifies the price.